Astec LifeSciences Limited — Board Meeting, 29-10-2025: Outcome of Board Meeting
29-10-2025 | 06:55 pm
29-10-2025 | 06:55 pm
Astec LifeSciences' Board approved the financial results for the quarter and half-year ended Sep 30, 2025. The company reported a consolidated revenue of ₹164.80 Cr and a loss of ₹57.44 Cr for the half-year. EPS stood at ₹(27.97). The auditors issued an unmodified opinion.
No comments yet. Be the first to comment!
